These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9368726)

  • 1. Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity.
    Henk JM
    Clin Oncol (R Coll Radiol); 1997; 9(5):308-12. PubMed ID: 9368726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic overview of radiation therapy effects in head and neck cancer.
    Zackrisson B; Mercke C; Strander H; Wennerberg J; Cavallin-Ståhl E
    Acta Oncol; 2003; 42(5-6):443-61. PubMed ID: 14596506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer.
    Adelstein DJ
    Curr Opin Oncol; 1998 May; 10(3):213-8. PubMed ID: 9619357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology.
    Bernier J; Bentzen SM
    Eur J Cancer; 2003 Mar; 39(5):560-71. PubMed ID: 12628834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiobiological modelling of the therapeutic ratio for the addition of synchronous chemotherapy to radiotherapy in locally advanced squamous cell carcinoma of the head and neck.
    Hartley A; Sanghera P; Glaholm J; Mehanna H; McConkey C; Fowler J
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):125-30. PubMed ID: 19880297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy and altered fractionation in head-and-neck cancer: in regard to Staar et al., IJROBP 2001;50:1161-1171.
    Bentzen SM; Bernier J
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1423; author reply 1423-4. PubMed ID: 11955758
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined modality treatment with radiotherapy and chemotherapy.
    Tannock IF
    Radiother Oncol; 1989 Oct; 16(2):83-101. PubMed ID: 2687956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of combined modality therapies for head and neck cancer.
    Dimery IW; Hong WK
    J Natl Cancer Inst; 1993 Jan; 85(2):95-111. PubMed ID: 8418313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology?
    Bernier J
    Nat Clin Pract Oncol; 2005 Jun; 2(6):305-14. PubMed ID: 16264988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In regard to Staar et al.: Intensified hyperfractionated accelerated radiotherapy limits the additional benefits of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer. IJROBP 2001;50:1161-1171.
    Grabenbauer GG; Sauer R
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):300. PubMed ID: 12183004
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiotherapy for cancer of the head and neck: altered fractionation regimens.
    Nguyen LN; Ang KK
    Lancet Oncol; 2002 Nov; 3(11):693-701. PubMed ID: 12424072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
    Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer.
    Blanchard P; Hill C; Guihenneuc-Jouyaux C; Baey C; Bourhis J; Pignon JP;
    J Clin Epidemiol; 2011 Sep; 64(9):985-92. PubMed ID: 21330105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined-modality therapy for head and neck cancer.
    Fu KK
    Oncology (Williston Park); 1997 Dec; 11(12):1781-90, 1796; discussion 1796, 179. PubMed ID: 9436185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How much radiation is the chemotherapy worth in advanced head and neck cancer?
    Kasibhatla M; Kirkpatrick JP; Brizel DM
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1491-5. PubMed ID: 17674979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonstandard fractionation schedules in radiation therapy of head and neck cancer: a review.
    Olmi P; Fallai C
    Tumori; 1997; 83(3):633-42. PubMed ID: 9267479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In response to Drs. Dubben, Beck-Bornholdt, and Llogie.
    Ang KK; Berkey BA; Pajak TF; Fu KK
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1148-50. PubMed ID: 11958923
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reirradiation of head and neck cancers].
    Comet B; Lartigau E
    Cancer Radiother; 2010 Oct; 14(6-7):416-20. PubMed ID: 20810299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.